Exploring protein aggregation and self‐propagation using lattice models: Phase diagram and kinetics

Many seemingly unrelated neurodegenerative disorders, such as amyloid and prion diseases, are associated with propagating fibrils whose structures are dramatically different from the native states of the corresponding monomers. This observation, along with the experimental demonstration that any protein can aggregate to form either fibrils or amorphous structures (inclusion bodies) under appropriate external conditions, suggest that there must be general principles that govern aggregation mechanisms. To probe generic aspects of prion‐like behavior we use the model of Harrison, Chan, Prusiner, and Cohen. In this model, aggregation of a structure, that is conformationally distinct from the native state of the monomer, occurs by three parallel routes. Kinetic partitioning, which leads to parallel assembly pathways, occurs early in the aggregation process. In all pathways transient unfolding precedes polymerization and self‐propagation. Chain polymerization is consistent with templated assembly, with the dimer being the minimal nucleus. The kinetic effciency of Rn−1 + G → Rn (R is the aggregation prone state and G is either U, the unfolded state, or N, the native state of the monomer) is increased when polymerization occurs in the presence of a “seed” (a dimer). These results support the seeded nucleated‐polymerization model of fibril formation in amyloid peptides. To probe generic aspects of aggregation in two‐state proteins, we use lattice models with side chains. The phase diagram in the (T,C) plane (T is the temperature and C is the polypeptide concentration) reveals a bewildering array of “phases” or structures. Explicit computations for dimers show that there are at least six phases including ordered structures and amorphous aggregates. In the ordered region of the phase diagram there are three distinct structures. We find ordered dimers (OD) in which each monomer is in the folded state and the interaction between the monomers occurs via a well‐defined interface. In the domain‐swapped structures a certain fraction of intrachain contacts are replaced by interchain contacts. In the parallel dimers the interface is stabilized by favorable intermolecular hydrophobic interactions. The kinetics of folding to OD shows that aggregation proceeds directly from U in a dynamically cooperative manner without populating partially structured intermediates. These results support the experimental observation that ordered aggregation in the two‐state folders U1A and CI2 takes place from U. The contrasting aggregation processes in the two models suggest that there are several distinct mechanisms for polymerization that depend not only on the polypeptide sequence but also on external conditions (such as C, T, pH, and salt concentration).

[1]  B. Hazenberg Amyloidosis , 1933, The Indian medical gazette.

[2]  N. Metropolis,et al.  Equation of State Calculations by Fast Computing Machines , 1953, Resonance.

[3]  J. Griffith,et al.  Nature of the Scrapie Agent: Self-replication and Scrapie , 1967, Nature.

[4]  J. Griffith,et al.  Self-replication and scrapie. , 1967, Nature.

[5]  M. Goldberg,et al.  Renaturation of Escherichia coli tryptophanase after exposure to 8 M urea. Evidence for the existence of nucleation centers. , 1974, European journal of biochemistry.

[6]  J. King,et al.  Protein Folding Intermediates and Inclusion Body Formation. , 1989, Bio/Technology.

[7]  D Thirumalai,et al.  Kinetics and thermodynamics of folding in model proteins. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Ken A. Dill,et al.  Aggregation of globular proteins , 1993 .

[9]  A. Godzik,et al.  A general method for the prediction of the three dimensional structure and folding pathway of globular proteins: Application to designed helical proteins , 1993 .

[10]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[11]  K A Dill,et al.  Side‐chain entropy and packing in proteins , 1994, Protein science : a publication of the Protein Society.

[12]  C. Colaco,et al.  Amyloid fibril formation , 1994, Bio/Technology.

[13]  R. Jaenicke Folding and association versus misfolding and aggregation of proteins. , 1998, Philosophical transactions of the Royal Society of London. Series B, Biological sciences.

[14]  D. Thirumalai,et al.  Kinetics of protein folding: Nucleation mechanism, time scales, and pathways , 1995 .

[15]  P. Lansbury,et al.  Non-genetic propagation of strain-specific properties of scrapie prion protein , 1995, Nature.

[16]  D. Yee,et al.  Principles of protein folding — A perspective from simple exact models , 1995, Protein science : a publication of the Protein Society.

[17]  T. Kiefhaber,et al.  Kinetic traps in lysozyme folding. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[18]  D Eisenberg,et al.  3D domain swapping: A mechanism for oligomer assembly , 1995, Protein science : a publication of the Protein Society.

[19]  J. King,et al.  Multimeric intermediates in the pathway to the aggregated inclusion body state for P22 tailspike polypeptide chains , 1995, Protein science : a publication of the Protein Society.

[20]  Andrew F. Hill,et al.  Molecular analysis of prion strain variation and the aetiology of 'new variant' CJD , 1996, Nature.

[21]  R. Riek,et al.  NMR structure of the mouse prion protein domain PrP(121–231) , 1996, Nature.

[22]  J. Kelly,et al.  Alternative conformations of amyloidogenic proteins govern their behavior. , 1996, Current opinion in structural biology.

[23]  S. Prusiner,et al.  Evidence for the Conformation of the Pathologic Isoform of the Prion Protein Enciphering and Propagating Prion Diversity , 1996, Science.

[24]  R. Wetzel For Protein Misassembly, It's the “I” Decade , 1996, Cell.

[25]  C M Dobson,et al.  Fast and slow tracks in lysozyme folding: insight into the role of domains in the folding process. , 1997, Journal of molecular biology.

[26]  M. Oliveberg,et al.  Transient aggregates in protein folding are easily mistaken for folding intermediates. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[27]  V. Muñoz,et al.  Submillisecond kinetics of protein folding. , 1997, Current opinion in structural biology.

[28]  Christopher M. Dobson,et al.  Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis , 1997, Nature.

[29]  P. Lansbury,et al.  Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins. , 1997, Annual review of biochemistry.

[30]  A. Fersht Nucleation mechanisms in protein folding. , 1997, Current opinion in structural biology.

[31]  F E Cohen,et al.  Pathologic conformations of prion proteins. , 1998, Annual review of biochemistry.

[32]  A. Fink Protein aggregation: folding aggregates, inclusion bodies and amyloid. , 1998, Folding & design.

[33]  P. Gupta,et al.  Effect of denaturant and protein concentrations upon protein refolding and aggregation: A simple lattice model , 1998, Protein science : a publication of the Protein Society.

[34]  D Thirumalai,et al.  Cooperativity in protein folding: from lattice models with sidechains to real proteins. , 1998, Folding & design.

[35]  R. Broglia,et al.  Folding and aggregation of designed proteins. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Stanley B. Prusiner,et al.  Nobel Lecture: Prions , 1998 .

[37]  F. Cohen,et al.  Eight prion strains have PrPSc molecules with different conformations , 1998, Nature Medicine.

[38]  F. Cohen,et al.  Thermodynamics of model prions and its implications for the problem of prion protein folding. , 1999, Journal of molecular biology.

[39]  M. Hecht,et al.  De novo amyloid proteins from designed combinatorial libraries. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C M Dobson,et al.  Designing conditions for in vitro formation of amyloid protofilaments and fibrils. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[41]  A. Fersht,et al.  Formation of short-lived protein aggregates directly from the coil in two-state folding. , 1999, Biochemistry.

[42]  Russell Schwartz,et al.  Lattice Simulations of Aggregation Funnels for Protein Folding , 1999, J. Comput. Biol..

[43]  Elena Orlova,et al.  Cryo‐electron microscopy structure of an SH3 amyloid fibril and model of the molecular packing , 1999, The EMBO journal.

[44]  A. Maritan,et al.  Compactness, aggregation, and prionlike behavior of protein: A lattice model study , 2000 .

[45]  R. Leapman,et al.  Amyloid Fibril Formation by Aβ16-22, a Seven-Residue Fragment of the Alzheimer's β-Amyloid Peptide, and Structural Characterization by Solid State NMR† , 2000 .

[46]  Francesca Massi,et al.  Energy landscape theory for Alzheimer's amyloid β‐peptide fibril elongation , 2001 .

[47]  D Thirumalai,et al.  Multiple protein folding nuclei and the transition state ensemble in two‐state proteins , 2001, Proteins.

[48]  A. V. Smith,et al.  Protein refolding versus aggregation: computer simulations on an intermediate-resolution protein model. , 2001, Journal of molecular biology.

[49]  F. Cohen,et al.  Conformational propagation with prion‐like characteristics in a simple model of protein folding , 2001, Protein science : a publication of the Protein Society.

[50]  Zbigniew Grzonka,et al.  Human cystatin C, an amyloidogenic protein, dimerizes through three-dimensional domain swapping , 2001, Nature Structural Biology.

[51]  David Eisenberg,et al.  A domain-swapped RNase A dimer with implications for amyloid formation , 2001, Nature Structural Biology.